Differential Expression of CXCR4 in Conventional High-grade and Low-grade Central Osteosarcoma and Its Prognostic Implications |
Park, Hye-Rim
(Department of Pathology, Hallym University College of Medicine)
Seo, Jin-Won (Department of Pathology, Hallym University College of Medicine) Bacchini, Patrizia (Servizio di Anatomia Pathologica, Istituto Ortopedico Rizzoli) Bertoni, Franco (Servizio di Anatomia Pathologica, Istituto Ortopedico Rizzoli) Park, Yong-Koo (Department of Pathology, Kyung Hee University College of Medicine) |
1 | Oda Y, Yamamoto H, Tamiya S, et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 2006;19:738-45. DOI |
2 | Chinni SR, Yamamoto H, Dong Z, Sabbota A, Bonfi l RD, Cher ML. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol Cancer Res. 2008;6:446-57. DOI |
3 | Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokines grammar for immune cells. Annu Rev Immunol. 2004;22:891-928. DOI |
4 | Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-6. DOI |
5 | Spano JP, Andre F, Morat L, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol. 2004;15:613-7. DOI |
6 | Scala S, Ottaiano A, Ascierto PA, et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res. 2005;11:1835-41. DOI |
7 | Koishi K, Yoshikawa R, Tsujimura T, et al. Persistent CXCR4 expression aft er preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol. 2006;12:7585-90. DOI |
8 | Jiang YP, Wu XH, Shi B, Wu WX, Yin GR. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol. 2006;103:226-33. DOI |
9 | Azenshtein E, Luboshits G, Shina S, et al. Th e CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 2002;62:1093-102. |
10 | Fan TM, Barger AM, Fredrickson RL, Fitzsimmons D, Garrett LD. Investigating CXCR4 expression in canine appendicular osteosarcoma. J Vet Intern Med. 2008;22:602-8. DOI |
11 | Laverdiere C, Hoang BH, Yang R, et al. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res. 2005;11:2561-7. DOI |
12 | Perissinotto E, Cavalloni G, Leone F, et al. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res. 2005;11:490-7. |
13 | Unni KK, Dahlin DC. Grading of bone tumors. Semin Diagn Pathol. 1984;1:165-72. |
14 | Paoletti S, Borzi RM, Mazzetti I, et al. Human osteosarcoma cells release matrix degrading enzymes in response to chemokine activation. Int J Oncol. 2001;18:11-6. |
15 | Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 2002;100:2597-606. DOI |
16 | Bai S, Wang D, Klein MJ, Siegal GP. Characterization of CXCR4 expression in chondrosarcoma of bone. Arch Pathol Lab Med. 2011;135:753-8. |
17 | Murakami T, Maki W, Cardones AR, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002;62:7328-34. |
18 | Smith MC, Luker KE, Garbow JR, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004;64:8604-12. DOI |
19 | Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62:1832-7. |
20 | de Nigris F, Rossiello R, Schiano C, et al. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/ angiogenesis and metastasis. Cancer Res. 2008;68:1797-808. DOI |
21 | Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62:7203-6. |
22 | Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 2004;14:171-9. DOI |
23 | Gobert M, Treilleux I, Bendriss-Vermare N, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infi ltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69:2000-9. DOI |
24 | von Luettichau I, Nathrath M, Burdach S, Huss R, Segerer S, Nelson PJ. Mononuclear infi ltrates in osteosarcoma and chemokine receptor expression. Clin Cancer Res. 2006;12:5253-4. DOI |
25 | Kim SY, Lee CH, Midura BV, et al. Inhibition of the CXCR4/ CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis. 2008;25:201-11. DOI |
26 | Takenaga M, Tamamura H, Hiramatsu K, et al. A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma. Biochem Biophys Res Commun. 2004;320:226-32. DOI |